J. Antonio G. Lopez, MD FAHA
The American Heart Association (AHA) has supported and played a pivotal role throughout my career in cardiovascular research, leading to my focus on the prevention and treatment of cardiovascular disease. Presently, I am the Director of Preventive Cardiology, the Lipid clinic, and LDL apheresis Program, and Hypertension Consultation Service at the Saint Alphonsus Regional Medical Center in Boise Idaho. Without the support for cardiovascular research, the understanding of disease processes that lead to important scientific advances would not be possible. Our current knowledge of risk factors (high cholesterol, low good cholesterol (HDL), diabetes, smoking, high blood pressure and family history of premature heart disease) leading to the development of atherosclerosis and coronary artery disease was based on epidemiologic research. Advocacy is fundamental to continue our progress.
I support advocacy on behalf of the American Heart Association chiefly for the health of our communities. For example, the AHA supports coverage of preventive benefits in private and public health insurance plans and the implementation of policies that provide adequate resources and encourage healthy choices. Locally, the AHA as a member of the Smokefree Idaho coalition is working to make communities across our state smoke free, inspiring more Americans to live in an environment that supports a heart-healthy lifestyle. Moreover, through our education efforts the AHA is reaching at-risk populations with cause initiatives and online tools. Thus, strong advocacy, sustained efforts, and programs such as “You’re The Cure” will significantly impact the reduction of cardiovascular disease.